Citation
Bi, Fangchao, et al. "Design, Synthesis and Structure-based Optimization of Novel Isoxazole-containing Benzamide Derivatives as FtsZ Modulators." European Journal of Medicinal Chemistry, vol. 159, 2018, pp. 90-103.
Bi F, Song D, Zhang N, et al. Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators. Eur J Med Chem. 2018;159:90-103.
Bi, F., Song, D., Zhang, N., Liu, Z., Gu, X., Hu, C., Cai, X., Venter, H., & Ma, S. (2018). Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators. European Journal of Medicinal Chemistry, 159, 90-103. https://doi.org/10.1016/j.ejmech.2018.09.053
Bi F, et al. Design, Synthesis and Structure-based Optimization of Novel Isoxazole-containing Benzamide Derivatives as FtsZ Modulators. Eur J Med Chem. 2018 Nov 5;159:90-103. PubMed PMID: 30268826.
TY - JOUR
T1 - Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators.
AU - Bi,Fangchao,
AU - Song,Di,
AU - Zhang,Nan,
AU - Liu,Zhiyang,
AU - Gu,Xinjie,
AU - Hu,Chaoyu,
AU - Cai,Xiaokang,
AU - Venter,Henrietta,
AU - Ma,Shutao,
Y1 - 2018/09/22/
PY - 2018/07/15/received
PY - 2018/09/19/revised
PY - 2018/09/19/accepted
PY - 2018/10/1/pubmed
PY - 2018/11/14/medline
PY - 2018/10/1/entrez
KW - Antibacterial activity
KW - FtsZ inhibitor
KW - Isoxazole-containing benzamide
KW - Molecular docking analysis
KW - Structure-based optimization
SP - 90
EP - 103
JF - European journal of medicinal chemistry
JO - Eur J Med Chem
VL - 159
N2 - Antibiotic resistance among clinically significant bacterial pathogens is becoming a prevalent threat to public health, and new antibacterial agents with novel mechanisms of action hence are in an urgent need. Utilizing computational docking method and structure-based optimization strategy, we rationally designed and synthesized two series of isoxazol-3-yl- and isoxazol-5-yl-containing benzamide derivatives that targeted the bacterial cell division protein FtsZ. Evaluation of their activity against a panel of Gram-positive and -negative pathogens revealed that compounds B14 and B16 that possessed the isoxazol-5-yl group showed strong antibacterial activity against various testing strains, including methicillin-resistant Staphylococcus aureus and penicillin-resistant S. aureus. Further molecular biological studies and docking analyses proved that the compound functioned as an effective inhibitor to alter the dynamics of FtsZ self-polymerization via a stimulatory mechanism, which finally terminated the cell division and caused cell death. Taken together, these results could suggest a promising chemotype for development of new FtsZ-targeting bactericidal agent.
SN - 1768-3254
UR - https://www.unboundmedicine.com/medline/citation/30268826/Design_synthesis_and_structure_based_optimization_of_novel_isoxazole_containing_benzamide_derivatives_as_FtsZ_modulators_
DB - PRIME
DP - Unbound Medicine
ER -